These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2109590)

  • 81. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus.
    Dalgleish AG; Beverley PC; Clapham PR; Crawford DH; Greaves MF; Weiss RA
    Nature; 1984 Dec 20-1985 Jan 2; 312(5996):763-7. PubMed ID: 6096719
    [TBL] [Abstract][Full Text] [Related]  

  • 82. T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV.
    Klatzmann D; Champagne E; Chamaret S; Gruest J; Guetard D; Hercend T; Gluckman JC; Montagnier L
    Nature; 1984 Dec 20-1985 Jan 2; 312(5996):767-8. PubMed ID: 6083454
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Fine structure of human immunodeficiency virus (HIV) and immunolocalization of structural proteins.
    Gelderblom HR; Hausmann EH; Ozel M; Pauli G; Koch MA
    Virology; 1987 Jan; 156(1):171-6. PubMed ID: 3643678
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Blocking of HIV-1 infectivity by a soluble, secreted form of the CD4 antigen.
    Smith DH; Byrn RA; Marsters SA; Gregory T; Groopman JE; Capon DJ
    Science; 1987 Dec; 238(4834):1704-7. PubMed ID: 3500514
    [TBL] [Abstract][Full Text] [Related]  

  • 85. A soluble form of CD4 (T4) protein inhibits AIDS virus infection.
    Deen KC; McDougal JS; Inacker R; Folena-Wasserman G; Arthos J; Rosenberg J; Maddon PJ; Axel R; Sweet RW
    Nature; 1988 Jan; 331(6151):82-4. PubMed ID: 3257544
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Efficient expression system for human antithrombin III in baby hamster kidney cells.
    Zettlmeissl G; Wirth M; Hauser H; Küpper HA
    Behring Inst Mitt; 1988 Apr; (82):26-34. PubMed ID: 3044341
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Binding of HTLV-III/LAV to T4+ T cells by a complex of the 110K viral protein and the T4 molecule.
    McDougal JS; Kennedy MS; Sligh JM; Cort SP; Mawle A; Nicholson JK
    Science; 1986 Jan; 231(4736):382-5. PubMed ID: 3001934
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry.
    Takeda A; Tuazon CU; Ennis FA
    Science; 1988 Oct; 242(4878):580-3. PubMed ID: 2972065
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Antibody-dependent enhancement of human immunodeficiency virus type 1 infection.
    Robinson WE; Montefiori DC; Mitchell WM
    Lancet; 1988 Apr; 1(8589):790-4. PubMed ID: 2895317
    [TBL] [Abstract][Full Text] [Related]  

  • 90. HIV-infected cells are killed by rCD4-ricin A chain.
    Till MA; Ghetie V; Gregory T; Patzer EJ; Porter JP; Uhr JW; Capon DJ; Vitetta ES
    Science; 1988 Nov; 242(4882):1166-8. PubMed ID: 2847316
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Selective killing of HIV-infected cells by recombinant human CD4-Pseudomonas exotoxin hybrid protein.
    Chaudhary VK; Mizukami T; Fuerst TR; FitzGerald DJ; Moss B; Pastan I; Berger EA
    Nature; 1988 Sep; 335(6188):369-72. PubMed ID: 2843774
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Soluble CD4 molecules neutralize human immunodeficiency virus type 1.
    Traunecker A; Lüke W; Karjalainen K
    Nature; 1988 Jan; 331(6151):84-6. PubMed ID: 2829024
    [TBL] [Abstract][Full Text] [Related]  

  • 93. A soluble CD4 protein selectively inhibits HIV replication and syncytium formation.
    Hussey RE; Richardson NE; Kowalski M; Brown NR; Chang HC; Siliciano RF; Dorfman T; Walker B; Sodroski J; Reinherz EL
    Nature; 1988 Jan; 331(6151):78-81. PubMed ID: 2829023
    [TBL] [Abstract][Full Text] [Related]  

  • 94. HIV infection is blocked in vitro by recombinant soluble CD4.
    Fisher RA; Bertonis JM; Meier W; Johnson VA; Costopoulos DS; Liu T; Tizard R; Walker BD; Hirsch MS; Schooley RT
    Nature; 1988 Jan; 331(6151):76-8. PubMed ID: 2829022
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Interaction between CD4 and class II MHC molecules mediates cell adhesion.
    Doyle C; Strominger JL
    Nature; 1987 Nov 19-25; 330(6145):256-9. PubMed ID: 2823150
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Highly efficient neutralization of HIV with recombinant CD4-immunoglobulin molecules.
    Traunecker A; Schneider J; Kiefer H; Karjalainen K
    Nature; 1989 May; 339(6219):68-70. PubMed ID: 2541344
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Designing CD4 immunoadhesins for AIDS therapy.
    Capon DJ; Chamow SM; Mordenti J; Marsters SA; Gregory T; Mitsuya H; Byrn RA; Lucas C; Wurm FM; Groopman JE
    Nature; 1989 Feb; 337(6207):525-31. PubMed ID: 2536900
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Genetic analysis of monoclonal antibody and HIV binding sites on the human lymphocyte antigen CD4.
    Peterson A; Seed B
    Cell; 1988 Jul; 54(1):65-72. PubMed ID: 2454749
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Detection of human immunodeficiency virus and other retroviruses in cell culture supernatants by a reverse transcriptase microassay.
    Gregersen JP; Wege H; Preiss L; Jentsch KD
    J Virol Methods; 1988 Feb; 19(2):161-8. PubMed ID: 2452827
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor.
    Lasky LA; Nakamura G; Smith DH; Fennie C; Shimasaki C; Patzer E; Berman P; Gregory T; Capon DJ
    Cell; 1987 Sep; 50(6):975-85. PubMed ID: 2441877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.